These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19239429)

  • 41. [Clinical and morphological characteristics of gastrointestinal stromal tumors].
    Kravtsov VG; Zaĭrat'iants OV
    Arkh Patol; 2007; 69(5):54-61. PubMed ID: 18074824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal stromal tumor: a clinical overview.
    Quek R; George S
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):69-78, viii. PubMed ID: 19248971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs).
    Price VE; Zielenska M; Chilton-MacNeill S; Smith CR; Pappo AS
    Pediatr Blood Cancer; 2005 Jul; 45(1):20-4. PubMed ID: 15795882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KIT codon 558 insertions in gastrointestinal stromal tumors. Analysis of 17 rare KIT mutants.
    Lasota J; Kuban W; Wardelmann E; Debiec-Rychter M; Merkelbach-Bruse S; Sciot R; Rys J; Steigen SE; Iwanik K; Holden JA; Jerzak Vel Dobosz A; Schildhaus HU; Miettinen M
    Hum Pathol; 2008 Dec; 39(12):1728-36. PubMed ID: 18715619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
    Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
    Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors.
    Romeo S; Debiec-Rychter M; Van Glabbeke M; Van Paassen H; Comite P; Van Eijk R; Oosting J; Verweij J; Terrier P; Schneider U; Sciot R; Blay JY; Hogendoorn PC;
    Clin Cancer Res; 2009 Jun; 15(12):4191-8. PubMed ID: 19509155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy.
    Nakai N; Ishikawa T; Nishitani A; Liu NN; Shincho M; Hao H; Isozaki K; Kanda T; Nishida T; Fujimoto J; Hirota S
    J Pathol; 2008 Feb; 214(3):302-11. PubMed ID: 18098338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours.
    Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M
    Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 17 year-old man with an exon 11 mutation of CD-117 causing a gastrointestinal stromal tumor.
    Bauer TM; Berlin JD
    Cancer Invest; 2008 Mar; 26(2):182-4. PubMed ID: 18259950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors.
    Lasota J; Miettinen M
    Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor.
    Zheng S; Pan YL; Tao DY; Wang JL; Huang KE
    Scand J Gastroenterol; 2009; 44(6):760-3. PubMed ID: 19096980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knock-in murine models of familial gastrointestinal stromal tumours.
    Gunawan B
    J Pathol; 2008 Mar; 214(4):407-9. PubMed ID: 18200631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastrointestinal stromal tumors: diagnostic challenges and practical approach to differential diagnosis.
    Kirsch R; Gao ZH; Riddell R
    Adv Anat Pathol; 2007 Jul; 14(4):261-85. PubMed ID: 17592256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal stromal tumors: the histology report.
    Dei Tos AP; Laurino L; Bearzi I; Messerini L; Farinati F; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S304-9. PubMed ID: 21459336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary pathology of gastrointestinal stromal tumors.
    Liegl B; Hornick JL; Lazar AJ
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):49-68, vii-viii. PubMed ID: 19248970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of KIT exon 11 deletions in GISTs.
    Emile JF; Tabone-Eglinger S; Théou-Anton N; Lemoine A
    Gastroenterology; 2006 Sep; 131(3):976-7; author reply 977-8. PubMed ID: 16952576
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.
    Parkin B; Chugh R
    Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnosis of gastrointestinal stromal tumors from minute specimens: cytomorphology, immunohistochemistry, and molecular diagnostic findings.
    Layfield LJ; Wallander ML
    Diagn Cytopathol; 2012 Jun; 40(6):484-90. PubMed ID: 22351482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.
    Ryu MH; Kang WK; Bang YJ; Lee KH; Shin DB; Ryoo BY; Roh JK; Kang JH; Lee H; Kim TW; Chang HM; Park JO; Park YS; Kim TY; Kim MK; Lee WK; Kang HJ; Kang YK
    Oncology; 2009; 76(5):326-32. PubMed ID: 19307738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors.
    Miselli F; Millefanti C; Conca E; Negri T; Piacenza C; Pierotti MA; Tamborini E; Pilotti S
    Am J Surg Pathol; 2008 May; 32(5):738-43. PubMed ID: 18360281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.